Posts Archive

Multiple Myeloma Research Consortium NCT03346135: Phase 2: Daratumumab After Stem Cell Transplant in Treating Patients With Multiple...

GMMG - The German Speaking Myeloma Multicenter Group GMMG-CONCEPT trial Isa-KRd NCT03104842: Phase 2 - Evaluation iNduction,...

Cleveland Clinic: How to Give Subcutaneous Chemotherapy Injections

NCT03275103: Phase 1 - Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) A Phase...

NCT03318861: Phase 1: Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma...

Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma NCT03338972: Phase 1...

(PRIME) NCT03288493: Phase 1/2 - P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) NCT03288493: Phase...

MajesTEC1 Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory...

NCT03218683: Phase 1/2: Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies....

IKEMA Isa-Kd Vs Kd Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In...

Cancer related fatigue (CRF) is the most common cancer side effect and can severely interfere with activities of daily living long after...

Penn Medicine, the Abramson Cancer Center: CAR-T Cell Therapy: Using Healthy Cells to Fight Cancer Learn more:...

NCT03269136 MAGNETISMM-1 RRMM NCT03269136: Phase 1 -PF-06863135 As Single Agent & with Immunomodulatory Agents In relapsed Myeloma To...

SITC - Society for Immunotherapy of Cancer IMMUNOTHERAPY: The Path to a Cancer Cure (For Patients) Learn more: Society for Immunotherapy...

Roswell Park Comprehensive Cancer Center REVLIMID (Lenalidomide) Maintenance Therapy Approved for Multiple Myeloma Patients Feb 23, 2017...

NCT03078452: Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy...

A Phase I Trial of B-cell Maturation Antigen (BCMA) Targeted EGFRt/BCMA-41BBz Chimeric Antigen Receptor (CAR) Modified T Cells With or...

Genetics of Multiple Myeloma for Patients - Rafael Fonseca MD Genetics of Multiple Myeloma for Patients - Rafael Fonseca MD Rafael...

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed...